|
1
|
Costigan M, Scholz J and Woolf CJ:
Neuropathic pain: A maladaptive response of the nervous system to
damage. Annu Rev Neurosci. 32:1–32. 2009. View Article : Google Scholar
|
|
2
|
Calvo M, Davies AJ, Hébert HL, Weir GA,
Chesler EJ, Finnerup NB, Levitt RC, Smith BH, Neely GG, Costigan M
and Bennett DL: The genetics of neuropathic pain from model
organisms to clinical application. Neuron. 104:637–653. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Campbell JN and Meyer RA: Mechanisms of
neuropathic pain. Neuron. 52:77–92. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tramullas M, Francés R, de la Fuente R,
Velategui S, Carcelén M, García R, Llorca J and Hurlé MA:
MicroRNA-30c-5p modulates neuropathic pain in rodents. Sci Transl
Med. 10:eaao62992018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Descalzi G, Mitsi V, Purushothaman I,
Gaspari S, Avrampou K, Loh YHE, Shen L and Zachariou V: Neuropathic
pain promotes adaptive changes in gene expression in brain networks
involved in stress and depression. Sci Signal. 471:eaaj15492017.
View Article : Google Scholar
|
|
6
|
Yao RW, Wang Y and Chen LL: Cellular
functions of long noncoding RNAs. Net Cell Biol. 21:542–551. 2019.
View Article : Google Scholar
|
|
7
|
Boon RA, Jaé N, Holdt L and Dimmeler S:
Long noncoding RNAs: From clinical genetics to therapeutic targets?
J Am Coll Cardiol. 67:1214–1226. 2016. View Article : Google Scholar
|
|
8
|
Long Y, Wang X, Youmans DT and Cech TR:
How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han W, Shi J, Cao J, Dong B and Guan W:
Latest advances of long non-coding RNA SNHG5 in human cancers. Onco
Targets Ther. 13:6393–6403. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen M, Yang Y, Zhang W, Li X, Wu J, Zou X
and Zeng X: Long noncoding RNA SNHG5 knockdown alleviates
neuropathic pain by targeting the miR-154-5p/CXCL13 axis. Neurochem
Res. 45:1566–1575. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shang Q, Yang Z, Jia R and Ge S: The novel
roles of circRNAs in human cancer. Mol Cancer. 18:62019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang T, Wan X, Alvarez AA, James CD, Song
X, Yang Y, Sastry N, Nakano I, Sulman EP, Hu B and Cheng SY: MIR93
(microRNA-93) regulates tumorigenicity and therapy response of
glioblastoma by targeting autophagy. Autophagy. 15:1100–1111. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhaskaran V, Yao Y, Bei F and Peruzzi P:
Engineering, delivery, and biological validation of artificial
microRNA clusters for gene therapy applications. Nat Protoc.
14:3538–3553. 2019. View Article : Google Scholar
|
|
14
|
Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang
X, Xiong H, Gurbani D, Li L, Liu Y and Liu A: MicroRNA-218
functions as a tumor suppressor in lung cancer by targeting
IL-6/STAT3 and negatively correlates with poor prognosis. Mol
Cancer. 16:1412017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun D, Yue B, Sun R, Wang T, Pang W, Kong
Q, Zhu D, Li N and Qin C: Laboratory animal-Guideline for ethical
review of animal welfare (GBT35892-2018), China. 2018. https://www.chinesestandard.net/PDF.aspx/GBT35892-2018February
6–2018
|
|
16
|
Zhao L, Han T, Li Y, Sun J, Zhang S, Liu
Y, Shan B, Zheng D and Shi J: The lncRNA SNHG5/miR-32 axis
regulates gastric cancer cell proliferation and migration by
targeting KLF4. Faseb J. 31:893–903. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chi JR, Yu ZH, Liu BW, Zhang D, Ge J, Yu Y
and Cao XC: SNHG5 promotes breast cancer proliferation by sponging
the miR-154-5p/PCNA axis. Mol Ther Nucleic Acids. 17:138–149. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Guo D, Zhao Y, Ren M, Lu G, Wang Y,
Zhang J, Mi C, He S and Lu X: Long non-coding RNA SNHG5 promotes
human hepatocellular carcinoma progression by regulating
miR-26a-5p/GSK3β signal pathway. Cell Death Dis. 9:8882018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang QY, Peng L, Chen Y, Liao LD, Chen JX,
Li M, Li YY, Qian FC, Zhang YX, Wang F, et al: Characterization of
super-enhancer-associated functional lncRNAs acting as ceRNAs in
ESCC. Mol Oncol. 14:2203–2230. 2020. View Article : Google Scholar
|
|
21
|
Zhao L, Guo H, Zhou B, Feng J, Li Y, Han
T, Liu L, Li L, Zhang S, Liu Y, et al: Long non-coding RNA SNHG5
suppresses gastric cancer progression by trapping MTA2 in the
cytosol. Oncogene. 35:5770–5780. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen Q, Zheng J, Wang X, Hu W and Jiang Y
and Jiang Y: lncRNA SNHG5 regulates cell apoptosis and inflammation
by miR-132/PTEN axis in COPD. Biomed Pharmacother. 126:1100162020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ju C, Zhou R, Sun J, Zhang F, Tang X, Chen
KK, Zhao J, Lan X, Lin S, Zhang Z and Lv XB: lncRNA SNHG5 promotes
the progression of osteosarcoma by sponging the miR-212-3p/SGK3
axis. Cancer Cell Int. 18:1412018. View Article : Google Scholar
|
|
24
|
Gao J, Zeng K, Liu Y, Gao L and Liu L:
lncRNA SNHG5 promotes growth and invasion in melanoma by regulating
the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. 12:169–179. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin H, Shen L, Lin Q, Dong C, Maswela B,
Illahi GS and Wu X: SNHG5 enhances Paclitaxel sensitivity of
ovarian cancer cells through sponging miR-23a. Biomed Pharmacother.
123:1097112020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Wang Z, Liu J and Yang H: Long
non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis
of osteosarcoma by targeting ROCK1. Biomed Pharmacother.
107:598–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Mou J, Cao L, Zhen S, Huang H and
Bao H: MicroRNA-142-3p relieves neuropathic pain by targeting high
mobility group box 1. Int J Mol Med. 41:501–510. 2018.PubMed/NCBI
|
|
28
|
Xu H, Yue C and Chen L:
Post-transcriptional regulation of soluble guanylate cyclase that
governs neuropathic pain in Alzheimer's disease. J Alzheimers Dis.
71:1331–1338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giese KP, Fedorov NB, Filipkowski RK and
Silva AJ: Autophosphorylation at Thr286 of the alpha
calcium-calmodulin kinase II in LTP and learning. Science.
279:870–873. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gleason MR, Higashijima S, Dallman J, Liu
K, Mandel G and Fetcho JR: Translocation of CaM kinase II to
synaptic sites in vivo. Nat Neurosci. 6:217–218. 2003. View Article : Google Scholar
|
|
31
|
Geddis MS and Rehder V: The
phosphorylation state of neuronal processes determines growth cone
formation after neuronal injury. J Neurosci Res. 74:210–220. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
VanBerkum MF and Goodman CS: Targeted
disruption of Ca(2+)-calmodulin signaling in Drosophila growth
cones leads to stalls in axon extension and errors in axon
guidance. Neuron. 14:43–56. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo F, Yang C, Chen Y, Shukla P, Tang L,
Wang LX and Wang ZJ: Reversal of chronic inflammatory pain by acute
inhibition of Ca2+/calmodulin-dependent protein kinase II. J
Pharmacol Exp Ther. 325:267–275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Luo F, Yang C, Kirkmire CM and
Wang ZJ: Acute inhibition of Ca2+/calmodulin-dependent protein
kinase II reverses experimental neuropathic pain in mice. J
Pharmacol Exp Ther. 330:650–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ferrari LF, Bogen O and Levine JD: Role of
nociceptor αCaMKII in transition from acute to chronic pain
(hyperalgesic priming) in male and female rats. J Neurosci.
33:11002–11011. 2013. View Article : Google Scholar
|
|
36
|
He Y, Chen Y, Tian X, Yang C, Lu J, Xiao
C, DeSimone J, Wilkie DJ, Molokie RE and Wang ZJ: CaMKIIα underlies
spontaneous and evoked pain behaviors in Berkeley sickle cell
transgenic mice. Pain. 157:2798–2806. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Atkins CM, Nozaki N, Shigeri Y and
Soderling TR: Cytoplasmic polyadenylation element binding
protein-dependent protein synthesis is regulated by
calcium/calmodulin-dependent protein kinase II. J Neurosci.
24:5193–5201. 2004. View Article : Google Scholar
|
|
38
|
Kitamura Y, Miyazaki A, Yamanaka Y and
Nomura Y: Stimulatory effects of protein kinase C and calmodulin
kinase II on N-methyl-D-aspartate receptor/channels in the
postsynaptic density of rat brain. J Neurochem. 61:100–109. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tartof SY, Slezak JM, Fischer H, Hong V,
Ackerson BK, Ranasinghe ON, Frankland TB, Ogun OA, Zamparo JM, Gray
S, et al: Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6
months in a large integrated health system in the USA: A
retrospective cohort study. Lancet. 398:1407–1416. 2021. View Article : Google Scholar
|
